DITTO Daily

Based in the UK, DITTO Daily focuses on providing scientifically formulated daily supplements for menstrual health, aiming to alleviate symptoms associated with various menstrual conditions. Their products empower individuals by promoting wellness and enabling conversations about female health. DITTO Daily, founded in 2024 and headquartered in London, UK, specializes in menstrual health supplements. The company recently pivoted to focus on developing targeted solutions for menstrual symptoms.

In August 2025, DITTO Daily raised GBP 1. 35 million in a funding round led by Eka Ventures, marking their first investment. The company has successfully completed one deal to date. DITTO's primary offering is its Cycle Supplement, a scientifically formulated daily supplement designed to alleviate various menstrual cycle symptoms such as PMS, PMDD, PCOS, and endometriosis.

The supplement combines a blend of ten nutrients, including Vitamin D, Zinc, Omega-3, Magnesium, and Calcium, with advanced nutrient delivery technology that allows for maximum absorption and gradual release of ingredients. This approach is intended to manage symptoms during menstruation and offer proactive support for menstrual health. DITTO products target individuals facing menstrual issues, particularly women, and are marketed in regions where female health and wellness products are in high demand, such as North America and Europe. DITTO generates revenue through a subscription model, allowing customers to receive their Cycle Supplements regularly.

Clients can opt for flexible subscription plans that include options for pausing or skipping deliveries, enhancing customer retention. The business structure focuses on direct-to-consumer sales, enabling it to maintain a close connection with its clientele for feedback. The Cycle Supplement is competitively priced, appealing to a demographic that values health and wellness solutions tailored to menstrual health, supported by a 30-day money-back guarantee. In August 2025, DITTO Daily raised GBP 1.

35 million in pre-seed funding led by Eka Ventures to support the launch of its supplement products and expansion plans. The company aims to introduce additional products designed specifically for women's health in the upcoming year, while also targeting expansion into new markets, particularly in Europe and North America, by mid-2026.